| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss attributable to common stockholders | -276,771 | - | - | -580,843 |
| Net loss per share basic and diluted | 0 | 0 | 0 | -0.01 |
| Weighted average common shares outstanding basic and diluted | 147,870,790 | 119,820,790 | 119,820,790 | 119,820,790 |
Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd (YBGJ)